Paul Parker, a former mergers and acquisitions banker turned health-care executive, is joining Flagship Pioneering Inc., the ...

We recently compiled a list of the Jim Cramer’s List of Stocks that Finished Dead Last. In this article, we are going to take ...

The US government has signed a $176 million deal with Moderna to develop an mRNA-based pandemic influenza vaccine, as reports emerge of a fifth human case of H5N1 flu linked to ongoing outbreaks ...

The US government has signed another big coronavirus vaccine supply deal, snapping up 100 million doses of Moderna’s mRNA jab for a little over $1.5 billion –around $15 per dose or $30 per course.

Pfizer and its German partner BioNTech on Tuesday won their attempt to invalidate two of rival CureVac's patents at London's ...

The rise in mRNA pharmaceuticals’ licensing agreement values suggests that this field will remain a major area for innovation ...

Advances in DNA sequencing and the vast amounts of genomic data being produced by next-generation sequencing (NGS) technology ...

US hedge fund Starboard now holds 0.6% of Pfizer’s value as the drugmaker struggles with its post-pandemic financial ...

Elon Musk appeared onstage at a rally for the former president this weekend, but Silicon Valley was abuzz about Ben ...

Novavax’s decision has left managers of the Biologics Manufacturing Centre, which was built with nearly $130-million in ...

Most investors unaware of the huge breakthroughs happening in biotech right now. But new technologies such as cancer-killing ...

NHS cancer patients to benefit from partnership with pharmaceutical companies and universities to spot cancer sooner through ...